Company / Return on Assets (ROA)
Decoy Therapeutics Inc. Return on Assets (ROA) History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-87.2%
FY2022
5-year range
-380.1% / -12.0%
FY2018-FY2022
Trend
-383.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -384% YoY in FY2022, a notable deviation from the 6-year average annual change of -216%.
Based on SEC 10-K filings.
-87.2% in FY2022 with a 5-year CAGR of -3.9%.
Declined from -27.8% to -87.2% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -75.1pp
- 5-Year Change
- -3.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, return on assets (roa) decreased 383.9% year-over-year.
- Peak return on assets (roa) was recorded in FY2019.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -87.2% | -383.9% |
| FY2021 | -18.0% | +35.3% |
| FY2020 | -27.8% | -131.4% |
| FY2019 | -12.0% | +96.8% |
| FY2018 | -380.1% | -356.4% |
| FY2017 | -83.3% | -557.3% |
| FY2016 | -12.7% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026